Abstract
A stable Cu(i)-carboxylate MOF is fabricated by ascorbic acid reduction, which breaks HSAB theory and achieves in situ phase transitions. The resultant Cu2H2DOBDC acting as a CuAAC catalyst exhibited superior catalytic performance.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have